SCHEMBL6334263

SCHEMBL6334263

CCCC(CCC)c1c(O)cccc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
TSHR P16473 1/20 0.39
NQO1 P15559 1/20 0.38
CA2 P00918 3/20 0.36
CA1 P00915 2/20 0.36
CA12 O43570 2/20 0.36
CA14 Q9ULX7 2/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
ALDH1A1 P00352 3/20 0.36
ATM Q13315 2/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
EGFR P00533 2/20 0.36
LMNA P02545 2/20 0.36
FYN P06241 2/20 0.36
MMP9 P14780 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1668678 0.92 MEN1 (0.40) ESR1ESR2TSHRALDH1A1ATM
SCHEMBL548702 0.91 TSHR (0.41) ESR1ESR2TSHRNQO1CA2
SCHEMBL6328901 0.90 MEN1 (0.42) ESR1ESR2NQO1ALDH1A1ATM
SCHEMBL6336590 0.89 MEN1 (0.45) NQO1ALDH1A1ATMMAPTMEN1
SCHEMBL6327063 0.89 MEN1 (0.45) NQO1ALDH1A1ATMMAPTMEN1
SCHEMBL6334758 0.89 MEN1 (0.45) NQO1ALDH1A1ATMMAPTMEN1
SCHEMBL725190 0.88 ESR1 (0.37) ESR1ESR2TSHRNQO1CA2
SCHEMBL2466445 0.87 MEN1 (0.42) TSHRALDH1A1ATMMAPTMEN1
SCHEMBL21137911 0.85 MEN1 (0.44) ALDH1A1ATMMAPTMEN1HTT
SCHEMBL16054167 0.84 MEN1 (0.43) ALDH1A1ATMMAPTMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026098831-A1 USE OF A PERSONAL CARE COMPOSITION FOR IMPROVING THE BARRIER FUNCTION OF SKIN UNILEVER IP HOLDINGS B.V. (NL) 2026-05-15 WO claimed
WO-2026041386-A1 ANHYDROUS COMPOSITION COMPRISING MONOESTERS AND MAINLY PETROLATUM UNILEVER IP HOLDINGS B.V. (NL) 2026-02-26 WO claimed
EP-3675806-B1 PERSONAL CARE COMPOSITION UNILEVER GLOBAL IP LTD (GB) 2026-01-21 EP claimed
EP-4637692-A1 COLOR STABILIZATION OF FORMULAE WITH AN INDOLE Unilever IP Holdings B.V. (NL) 2025-10-29 EP claimed
WO-2025132281-A1 COSMETIC COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2025-06-26 WO claimed
WO-2024132395-A1 COLOR STABILIZATION OF FORMULAE WITH AN INDOLE UNILEVER IP HOLDINGS B.V. (NL) 2024-06-27 WO claimed
US-11478411-B2 Use of chelating agents for improving color stability of resorcinol CONOPCO, INC. (US) 2022-10-25 US claimed
US-11324679-B2 Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors CONOPCO, INC. (US) 2022-05-10 US claimed
US-20210106509-A1 A sunscreen composition CONOPCO, INC., D/B/A UNILEVER (US) 2021-04-15 US claimed
EP-3784355-A1 A SUNSCREEN COMPOSITION Unilever N.V. (NL) 2021-03-03 EP claimed
US-6869598-B2 Stabilization of sunscreens in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) 2005-03-22 US claimed
US-6863897-B2 Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) 2005-03-08 US claimed
US-6858217-B2 Stabilization of terpenoids in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) 2005-02-22 US claimed
EP-1490017-A1 STABILIZATION OF SUNSCREENS IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2004-12-29 EP claimed
US-20030185773-A1 Stabilization of sunscreens in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-10-02 US claimed
US-20030185867-A1 Stabilization of terpenoids in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-10-02 US claimed
WO-2003080011-A1 STABILIZATION OF TERPENOIDS IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2003-10-02 WO claimed
WO-2003080009-A1 STABILIZATION OF SUNSCREENS IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2003-10-02 WO claimed
WO-2003080002-A1 STABILIZATION OF RESORCINOL DERIVATIVES IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2003-10-02 WO claimed
US-20030180234-A1 Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, 2003-09-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030185773-A1 Stabilization of sunscreens in cosmetic compositions RCOR1, CBR1, NQO1 ESR1 1321/4885ESR2 1091/4885TSHR 2772/4885
US-11324679-B2 Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors RARA, RARB, RBP4 ESR1 2248/4885ESR2 905/4885TSHR 3173/4885
US-20030180234-A1 Stabilization of resorcinol derivatives in cosmetic compositions RCOR1, RCOR3, MCOLN2 ESR1 1782/4885ESR2 1120/4885TSHR 1528/4885
US-20030185867-A1 Stabilization of terpenoids in cosmetic compositions SQLE, CYP51A1, RBP4 ESR1 1235/4885ESR2 1132/4885TSHR 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.